BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Salvia Miltiorrhiza

200+ PubMed studies analyzed · Evidence Score: 33.9

Research Domains

Salvia Miltiorrhiza has been studied across 10 research domains including 🔬 Inflammation, 🔬 Oncology, 🧘 Stress & Anxiety, 🛡️ Immunity, ❤️ Cardiovascular. The primary research focus is 🔬 Inflammation with 11% of studies addressing this area.

Traditional Use (Ayurveda)

Known as danshen / 丹參 in Ayurveda. Virya (potency): Heart, Liver. Karma (actions): Tonifies Blood, Tonifies Qi, Breaks accumulations, Eliminates concretions, Expels wind evil, Settles the Essence, Nourishes the Shen, Stabilizes the will, Promotes passage and expels dead fetus, Stops blood flooding and vaginal discharge, Regulates the menstrual vessels, Drains pus and stops pain, Engenders muscle and promotes flesh growth, Invigorates Blood, Frees the Heart Pericardium collateral.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Salvia Miltiorrhiza, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

achyranthes
6718 shared targets
Garlic
7283 shared targets
polygonum
6267 shared targets
eucommia
6549 shared targets
aloe
7454 shared targets
trichosanthes
6474 shared targets
glycyrrhiza
6316 shared targets
scutellaria
6684 shared targets
prunus
6469 shared targets
ziziphus
6992 shared targets
Loading evidence profile...

This evidence profile for Salvia Miltiorrhiza is generated deterministically from 200 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.